Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1114]
News [2422]
Articles [145]
Editorials [8]
Conferences [99]
elearning [11]
Enfortumab vedotin in combination with pembrolizumab is a potential new...
Dr Michiel Simon Van Der Heijden - Netherlands Cancer Institute, Amsterdam...
Enfortumab vedotin in combination with pembrolizumab is a potential new standard of care for 1L la/mUC ( Dr Michiel Simon Van Der Heijden - Netherlands Cancer Institute, Amsterdam, Netherlands )
30 Jan 2024
Enzalutamide monotherapy prolongs MFS compared to leuprolide alone in men with...
Dr Neal Shore - Carolina Urologic Research Center, Myrtle Beach, USA
Enzalutamide monotherapy prolongs MFS compared to leuprolide alone in men with high-risk biochemically recurrent PC ( Dr Neal Shore - Carolina Urologic Research Center, Myrtle Beach, USA )
30 Jan 2024
Personalised systemic treatment in advanced prostate cancer
Dr Karim Fizazi - Institute Gustave Roussy, Villejuif, France
Personalised systemic treatment in advanced prostate cancer ( Dr Karim Fizazi - Institute Gustave Roussy, Villejuif, France )
25 Jan 2024
World Bladder Cancer Patient Coalition
Dr Lydia Makaroff - President, World Bladder Cancer Patient Coalition, Oxford...
World Bladder Cancer Patient Coalition ( Dr Lydia Makaroff - President, World Bladder Cancer Patient Coalition, Oxford, UK )
8 Jan 2024
DNA methylation profile of prostate cancer aggressiveness in Ghana
Dr Alexandra Lindsey Djomkam Zune - West African Centre for Cell Biology of...
DNA methylation profile of prostate cancer aggressiveness in Ghana ( Dr Alexandra Lindsey Djomkam Zune - West African Centre for Cell Biology of Infectious Pathogens, Accra, Ghana )
3 Jan 2024
Latest developments in the treatment of bladder cancer
Dr Alison Birtle, Dr Ignacio Durán, Dr Friederike Schlürmann, Dr Yohann Loriot...
Latest developments in the treatment of bladder cancer ( Dr Alison Birtle, Dr Ignacio Durán, Dr Friederike Schlürmann, Dr Yohann Loriot and Dr Peter Goebell )
7 Dec 2023
ESMO 2023: Highlights and analysis
Dr Bishal Gyawali - Queen's University, Kingston, Canada
ESMO 2023: Highlights and analysis ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )
8 Nov 2023
Adjuvant radiotherapy has no benefit following radical prostatectomy
Prof Noel Clarke - The Christie NHS Foundation Trust, Manchester, UK
Adjuvant radiotherapy has no benefit following radical prostatectomy ( Prof Noel Clarke - The Christie NHS Foundation Trust, Manchester, UK )
27 Oct 2023
PARPi combinations to treat patients with mCRPC
Prof Axel Merseburger, Prof Karim Fizazi, Prof Laura-Maria Krabbe and Prof...
PARPi combinations to treat patients with mCRPC ( Prof Axel Merseburger, Prof Karim Fizazi, Prof Laura-Maria Krabbe and Prof Gerhardt Attard )
25 Oct 2023
Where do we stand with mCRPC?
Dr Neal Shore, Prof Neeraj Agarwal, Dr Pasquale Rescigno and Dr Friederike...
Where do we stand with mCRPC? ( Dr Neal Shore, Prof Neeraj Agarwal, Dr Pasquale Rescigno and Dr Friederike Schlurmann )
25 Oct 2023
ESMO 2023: Latest updates in mRCC
Dr Javier Puente, Dr Laurence Albiges, Prof Viktor Grünwald and Prof Stéphane...
ESMO 2023: Latest updates in mRCC ( Dr Javier Puente, Dr Laurence Albiges, Prof Viktor Grünwald and Prof Stéphane Oudard )
23 Oct 2023
Enfortumab vedotin plus pembrolizumab improves overall survival for advanced...
Prof Thomas Powles - Barts Cancer Centre, London, UK
Enfortumab vedotin plus pembrolizumab improves overall survival for advanced bladder cancer ( Prof Thomas Powles - Barts Cancer Centre, London, UK )
22 Oct 2023

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation